You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

305 Results
Drug
Other Name(s): Tykerb®
Sep 2025
Drug
Other Name(s): Lanvis®
Jun 2019
Drug
Other Name(s): Camptosar®
Sep 2025
Drug
Other Name(s): Caelyx®
Sep 2025
Drug
Other Name(s): Zolinza®
Jun 2019
Drug
Other Name(s): Imbruvica®
Sep 2025
Drug
Other Name(s): Keytruda®
Sep 2025
Drug
Other Name(s): Ninlaro™
Jun 2019
Regimen
Intent: Palliative, Curative
Funding:
New Drug Funding Program
    Aldesleukin (interleukin-2) - In-Transit Metastases from Melanoma
May 2019
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Nov 2019
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Funding:
ODB - General Benefit
    dexamethasone
Sep 2019
Regimen

Pages